DeepakLBhattMDMPH, MBA

Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Preventive Cardiology, Vascular Medicine

Director of the Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai in New York City

Join to view full profile

Dr. Bhatt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bhatt's full profile

Already have an account?

Office
1190 5th Avenue at 101st Street, Box 1030
New York, NY 10029
Phone+1 212-241-5174

Fax+1 212-241-3148

Summary

Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, is the Director of the Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai in New York City.

After graduating as valedictorian from Boston Latin School, Dr. Bhatt obtained his science degree as a National Merit Scholar at MIT. He received his MD from Cornell, an MPH from Harvard, and an Executive MBA from Oxford. He trained in internal medicine at the University of Pennsylvania and in cardiology at Cleveland Clinic. He completed fellowships in interventional cardiology and cerebral and peripheral vascular intervention and served as Chief Interventional Fellow at Cleveland Clinic, where he spent many years as an interventional cardiologist, Associate Professor of Medicine, Director of the Interventional Cardiology Fellowship, Associate Director of the Cardiovascular Medicine Fellowship, and Associate Director of the Cardiovascular Coordinating Center. He then served as the Chief of Cardiology at VA Boston Healthcare System and subsequently as Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital. He was a Senior Investigator in the TIMI Study Group and Editor-in-Chief of the Harvard Heart Letter. He became a full Professor of Medicine at Harvard Medical School in 2012. He was selected by Brigham and Women’s Hospital as the 2014 Eugene Braunwald Scholar. He has been listed in Best Doctors in America from 2005 to 2020. He received the Research Mentor Award from Brigham and Women’s Hospital Department of Medicine in 2016, the Eugene Braunwald Teaching Award for Excellence in the Teaching of Clinical Cardiology from Brigham and Women’s Hospital in 2017, ACC’s Distinguished Mentor Award in 2018, AHA’s Distinguished Scientist Award in 2019, NLA’s Honorary Lifetime Membership Award in 2021, and SCAI’s Master designation in 2022.

Education & Training

University of OxfordExecutive MBA, 2021 - 2024
Harvard School of Public HealthMPH, Clinical Effectiveness, 2007 - 2008
Cleveland Clinic FoundationFellowship, Interventional Cardiology, 1999 - 2001
Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1996 - 1999
University of Pennsylvania Health SystemResidency, Internal Medicine, 1994 - 1996
University of Pennsylvania Health SystemInternship, Internal Medicine, 1993 - 1994
Weill Cornell MedicineClass of 1993
Massachusetts Institute of TechnologyBS, Science, 1985 - 1989

Certifications & Licensure

NY State Medical License 2022 - 2026
RI State Medical License 2018 - 2026
MA State Medical License 2008 - 2025
OH State Medical License 2000 - 2025
PA State Medical License 1994 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Master Interventionalist of SCAI (MSCAI) Society for Cardiovascular Angiography and Interventions, 2022
Honorary Lifetime Membership Award National Lipid Association, 2021
Distinguished Scientist Award American Heart Association, 2019
Distinguished Mentor Award American College of Cardiology, 2018
Join now to see all

Clinical Trials

Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes Start of enrollment: 2005 Dec 01
Terminated
Phase 3
A Clinical Trial to Demonstrate the Efficacy of Cangrelor Start of enrollment: 2006 Apr 01
Terminated
Phase 3
Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition. Start of enrollment: 2006 Sep 01
Terminated
Phase 3
The BEACON Registry: Best Expert Agreement for Care of Occult Myocardial Infarction (MI) Nationally Start of enrollment: 2007 Nov 01
Terminated
Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels Start of enrollment: 2005 Sep 01
Terminated
Phase 4
Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications Start of enrollment: 2010 May 01
Completed
Phase 4
Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty Start of enrollment: 2012 Jan 11
Completed
Phase 4
SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension Start of enrollment: 2011 Sep 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

964 citations
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
Deepak L. Bhatt, Michael Szarek, P. Gabriel Steg, Christopher P. Cannon, Lawrence A. Leiter
The New England Journal of Medicine. 2021-01-14
60 citations
Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis
Orly Leiva, Duaa AbdelHameid, Jean M. Connors, Christopher P. Cannon, Deepak L. Bhatt
JACC. Cardiooncology. 2021-11-01
633 citations
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.
Kevin S. Shah, Haolin Xu, Roland A. Matsouaka, Deepak L. Bhatt, Paul A. Heidenreich
Journal of the American College of Cardiology. 2017-11-14

Journal Articles

Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients with High-Risk Cardiovascular...
Jacob A Udell, Sheila M Hegde, Deepak L Bhatt, J Michael Gaziano, Kristin Nichol, Matthew C Tattersall, Jonathan L Temte, Clyde Yancy, JAMA
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
Deepak L Bhatt, Darren K Mcguire, Jeffrey M Testani, Pablo Lapuerta, Bertram Pitt, The New England Journal of Medicine
Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction with Multivessel Coronary Artery Disea...
Eric A Secemsky, Jeptha P Curtis, Salim S Virani, Ehrin J Armstrong, Kendrick A Shunk, Ralph G Brindis, Deepak Bhatt, Robert W Yeh, JAMA Cardiology
A Revolution in Omega-3 Fatty Acid Research
Deepak Bhatt, MD, JACC: Cardiovascular Imaging
Trends in Reperfusion Therapy for in-Hospital Ischemic Stroke in the Endovascular Therapy Era
Feras Akbik, Ying Xian, Eric E Smith, Deepak L Bhatt, Gregg C Fonarow, Lee H Schwamm, JAMA Neurology
Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized with Heart Failure
Rishi K Wadhera, Paul A Heidenreich, Clyde W Yancy, Deepak L Bhatt, JAMA Cardiology
Revascularization Practices and Outcomes in Patients with Multivessel Coronary Artery Disease Who Presented with Acute Myocardial Infarction and Cardiogenic Shock in t...
Rohan Khera, Eric A Secemsky, Harlan M Krumholz, Kendrick A Shunk, Salim S Virani, Deepak L Bhatt, Jeptha Curtis, Robert W Yeh, JAMA Internal Medicine
Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines
Nicholas A Marston, Marc P Bonaca, Petr Jarolim, Deepak L Bhatt, Stephen D Wiviott, Eugene Braunwald, Marc S Sabatine, JAMA Cardiology
Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers
Enrico G Ferro, Deepak L Bhatt, JAMA
Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients with Acute Ischemic Stroke
Shumei Man, Jeffrey L Saver, Eric E Smith, Deepak L Bhatt, Lee H Schwamm, Gregg C Fonarow, JAMA
Performance of Hospitals When Assessing Disease-Based Mortality Compared with Procedural Mortality for Patients with Acute Myocardial Infarction
Ashwin S Nathan, Rishi K Wadhera, Deepak L Bhatt, Daniel M Kolansky, Ajay J Kirtane, Robert W Yeh, Tracy Y Wang, Jay Giri, JAMA Cardiology
Dabigatran Dual Therapy with Ticagrelor or Clopidogrel After Percutaneous Coronary Intervention in Atrial Fibrillation Patients with or Without Acute Coronary Syndrome...
Christopher P Cannon, Deepak L Bhatt, European Heart Journal
Coronary Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention: A Subgroup Analysis of the PRESERVE Trial
Paul M Palevsky, Santiago Garcia, Deepak L Bhatt, Steven D Weisbord, ScienceDirect
Editorial Comment Insights from Autopsies: Potential Role of Thrombus in Structural Valve Deterioration∗
Deepak L Bhatt, Ron Blankstein, ScienceDirect
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D Wiviott, Marc S Sabatine, Christian T Ruff, Marc P Bonaca, Deepak L Bhatt, Darren K McGuire, The New England Journal of Medicine
Alirocumab and Cardiovascular Outcomes After Acute Coronary Syndrome
Vera A Bittner, Kenneth W Mahaffey, Deepak L Bhatt, Robert A Harrington, Gregory G Schwartz, Matthew T Roe, The New England Journal of Medicine
Drug-Eluting Versus Bare-Metal Stents in Older Patients: A Meta-Analysis of Randomized Controlled Trials
Deepak L Bhatt, Tarek Haykal, Meghan Gwinn, Babikir Kheiri, Ghassan Bachuwa, ScienceDirect
Short Communication Electronic Health Records and Outpatient Cardiovascular Disease Care Delivery: Insights from the American College of Cardiology’s PINNACLE India Qu...
Thomas M Maddox, Deepak L Bhatt, Salim S Virani, ScienceDirect
Mini Focus on Diabetes Original Investigation Hypoglycemia and Elevated Troponin in Patients with Diabetes and Coronary Artery Disease
Brendan M Everett, Mark A Hlatky, Robert L Frye, Trevor J Orchard, Deepak L Bhatt, ScienceDirect
Fractional Flow Reserve Measurement for the Physiological Assessment of Coronary Artery Stenosis Severity
Deepak Bhatt, MD, JAMA
Impact of Lesion Complexity on Peri-Procedural Adverse Events and the Benefit of Potent Intravenous Platelet Adenosine Diphosphate Receptor Inhibition After Percutaneo...
Gregg W Stone, Matthew J Price, Philippe Genereux, C Michael Gibson, Deepak L Bhatt, Robert A Harrington, Kenneth W Mahaffey, European Heart Journal
Original Investigation Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients
Navkaranbir S Bajaj, Ron Blankstein, Sharmila Dorbala, Ankur Gupta, Deepak L Bhatt, Viviany R Taqueti, Ali Tavakkoli, ScienceDirect
Standardized Classification and Framework for Reporting, Interpreting, and Analysing Medication Non-Adherence in Cardiovascular Clinical Trials: A Consensus Report fro...
Dominick J Angiolillo, Gregg W Stone, Roxana Mehran, Deepak L Bhatt, Usman Baber, European Heart Journal
Aspirin-Free Strategies in Cardiovascular Disease and Cardioembolic Stroke Prevention
Dominick J Angiolillo, Francesco Franchi, George Dangas, Usman Baber, C Michael Gibson, Deepak L Bhatt, Nature
Clinical Research Impact of Body Mass Index on Heart Failure by Race/Ethnicity from the Get with the Guidelines–Heart Failure (GWTG–HF) Registry
Gregg C Fonarow, Clyde Yancy, Deepak L Bhatt, Michelle A Albert, ScienceDirect
Join now to see all

Lectures

New Opportunities to Improve Management of Patients with or at High Risk of ASCVD Events: You Weigh the Evidence
Double Vs. Triple Therapy Among Patients Needing Oral Anticoagulation and Dual Antiplatelet Therapy: Insights From Clinical Trials
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Reduction in Total Ischemic Events with Icosapent Ethyl in REDUCE-IT
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Reduction in Total Ischemic Events with Icosapent Ethyl in REDUCE-IT
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Cangrelor: The New Standard of Care in STEMI
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Coronary Artery Disease Challenges in 2019: Cardiovascular Update for the Clinician-
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
First Randomized Human Experience with a Ticagrelor Reversal Agent
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Making the Most Out of ACC.org: Optimizing Your Experience With Your Digital Home
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
STEMI vs NSTEMI: PCI Culprit Lesion Alone CULPRIT-SHOCK Study vs FFR Guided Complete Revascularization Retrospective Studies
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Interventional Cardiology: Structural
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Join now to see all

Authored Content

Revascularization Practices and Outcomes in Patients with Multivessel Coronary Artery Disease Who Presented with Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018August 2020
Eagle's Eye View: Your Weekly CV Update from ACC.org (Week of August 17)August 2020
Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol GuidelinesAugust 2020
Antithrombotic Therapy in Patients with SIHDJuly 2020
Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care WorkersJuly 2020
Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care WorkersJuly 2020
Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients with Acute Ischemic StrokeJune 2020
Cost-Effectiveness of Alirocumab in Patients with Acute Coronary Syndromes the ODYSSEY OUTCOMES TrialMay 2020
Cost-Effectiveness of Alirocumab in Patients with Acute Coronary Syndromes the ODYSSEY OUTCOMES TrialMay 2020
Cost-Effectiveness of Alirocumab in Patients with Acute Coronary Syndromes the ODYSSEY OUTCOMES TrialMay 2020
Performance of Hospitals When Assessing Disease-Based Mortality Compared with Procedural Mortality for Patients with Acute Myocardial InfarctionMay 2020
Video: Day 3 Highlights | ACC.20/WCC VirtualMarch 2020
Eagle's Eye View: Day 3 Highlights | ACC.20/WCC VirtualMarch 2020
Video: Day 3 Overview | ACC.20/WCC VirtualMarch 2020
Video: Day 3 Highlights | ACC.20/WCC VirtualMarch 2020
Video: Day 3 Overview | ACC.20/WCC VirtualMarch 2020
Video: Day 2 Highlights | ACC.20/WCC VirtualMarch 2020
Video: Day 1 Highlights | ACC.20/WCC VirtualMarch 2020
Video: Day 1 Overview | ACC.20/WCC VirtualMarch 2020
Aspirin for Primary Prevention of Cardiovascular Disease?February 2019
The New Cholesterol Guidelines: What You Need to KnowNovember 2018
Aspirin for Primary Prevention of Cardiovascular Disease?September 2018
ESC Congress 2018 | Day 4 HighlightsAugust 2018
ESC Congress 2018 | Day 2 HighlightsAugust 2018
ESC Congress 2018 | Day 1 HighlightsAugust 2018
Antithrombotic Therapy for Peripheral Artery Disease Recent AdvancesMay 2018
Reply Cardiovascular Risk Models and Statin TherapyMay 2018
Lack of Association Between Heart Failure and Incident CancerApril 2018
Aortic Valve Replacement in an Era of Rapid Innovation Better the Devil You KnowMarch 2018
Long-Term Outcomes of Post-Operative Atrial Fibrillation Guilty as ChargedFebruary 2018
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients with Multivessel Coronary DiseaseJanuary 2018
Cardiovascular Risk and Statin Eligibility of Young Adults After an MI Partners YOUNG-MI RegistryJanuary 2018
Cardiovascular Risk and Statin Eligibility of Young Adults After an MI Partners YOUNG-MI RegistryJanuary 2018
Cardiovascular Risk and Statin Eligibility of Young Adults After an MI Partners YOUNG-MI RegistryJanuary 2018
Reply Cost-Effectiveness of Long-Term Ticagrelor in Patients with Prior Myocardial Infarction: Analysis by SubgroupsJanuary 2018
2017 AHA/ACC Clinical Performance and Quality Measures for Adults with ST-Elevation and Non–ST-Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Performance MeasuresOctober 2017
Dual Antithrombotic Therapy with Dabigatran After PCI in Atrial FibrillationAugust 2017
Join now to see all

Press Mentions

Prolocor Announces Publication of Confirmatory Results from Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)October 21st, 2024
TRANSFORMing the Primary Prevention of Coronary Heart Disease with AI/CCTAOctober 7th, 2024
Doctors Reveal the Signs a Young and ‘Super-Fit’ Person Is About to Suffer a Heart Attack Amid Worrying SurgeOctober 4th, 2024
Join now to see all